BR112015018444A2 - composição para prevenir infecção de mycoplasma spp., e vetor de expressão - Google Patents

composição para prevenir infecção de mycoplasma spp., e vetor de expressão

Info

Publication number
BR112015018444A2
BR112015018444A2 BR112015018444-8A BR112015018444A BR112015018444A2 BR 112015018444 A2 BR112015018444 A2 BR 112015018444A2 BR 112015018444 A BR112015018444 A BR 112015018444A BR 112015018444 A2 BR112015018444 A2 BR 112015018444A2
Authority
BR
Brazil
Prior art keywords
infection
composition
expression vector
mycoplasma spp
prevent mycoplasma
Prior art date
Application number
BR112015018444-8A
Other languages
English (en)
Inventor
Lin Jiunn-Horng
Wang Jyh-Perng
Hsieh Ming-Wei
Chen Zeng-Weng
Fang Chien-Yu
Liu Hsueh-Tao
Yang Ping-Cheng
Original Assignee
Agricultural Technology Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Technology Research Institute filed Critical Agricultural Technology Research Institute
Publication of BR112015018444A2 publication Critical patent/BR112015018444A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112015018444-8A 2013-02-05 2013-02-05 composição para prevenir infecção de mycoplasma spp., e vetor de expressão BR112015018444A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/071379 WO2014121433A1 (zh) 2013-02-05 2013-02-05 抗霉浆菌的亚单位疫苗

Publications (1)

Publication Number Publication Date
BR112015018444A2 true BR112015018444A2 (pt) 2018-05-08

Family

ID=51299148

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015018444-8A BR112015018444A2 (pt) 2013-02-05 2013-02-05 composição para prevenir infecção de mycoplasma spp., e vetor de expressão

Country Status (14)

Country Link
US (7) US9561267B2 (pt)
EP (3) EP3733691A1 (pt)
JP (1) JP6113306B2 (pt)
KR (7) KR101775434B1 (pt)
CN (1) CN104918953B (pt)
BR (1) BR112015018444A2 (pt)
DK (1) DK2955192T3 (pt)
ES (1) ES2812552T3 (pt)
MX (2) MX370715B (pt)
PH (1) PH12015501716B1 (pt)
RU (1) RU2636459C2 (pt)
TW (1) TWI609878B (pt)
UA (2) UA116431C2 (pt)
WO (1) WO2014121433A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2714000T3 (es) * 2013-11-21 2019-05-24 Agricultural Tech Res Inst Composición para prevenir y curar una infección por micoplasma
EP3166617B1 (en) 2014-07-07 2024-01-10 LifeRaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
CN106139137A (zh) * 2015-03-30 2016-11-23 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
WO2017011919A1 (en) * 2015-07-22 2017-01-26 University Of Saskatchewan Mycoplasma vaccines and uses thereof
ES2881625T3 (es) * 2015-12-28 2021-11-30 Agricultural Tech Res Inst Método de preparación de la proteína de la cápside del circovirus porcino tipo 2 y composición farmacéutica que la comprende
WO2018027526A1 (zh) * 2016-08-09 2018-02-15 财团法人农业科技研究院 防治猪鼻霉浆菌感染的组合物及生产该组合物的方法
TWI606839B (zh) * 2016-08-09 2017-12-01 財團法人農業科技研究院 防治豬鼻黴漿菌感染之組合物及生產該組合物的方法
JP7082196B2 (ja) * 2017-11-01 2022-06-07 アグリカルチュラル テクノロジー リサーチ インスティテュート マイコプラズマ・シノビエ感染を予防または治療するための組成物
RU2737971C1 (ru) * 2020-05-22 2020-12-07 Эгрикалчурал Текнолоджи Рисерч Инститьют Композиция для профилактики и лечения инфекции mycoplasma hyorhinis и способ получения указанной композиции

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE134705T1 (de) * 1988-06-29 1996-03-15 Ml Technology Ventures Rekombinantes hyopneumoniae antigen und dessen verwendung
EP0571648A1 (en) * 1992-05-26 1993-12-01 Chung-Nan Weng Vaccine protecting against mycoplasmal pneumonia
AU657859B2 (en) * 1992-05-29 1995-03-23 Nippon Zeon Co., Ltd. Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same
DE19816334A1 (de) 1998-04-11 1999-10-14 Krupp Uhde Gmbh Elektrolyseapparat zur Herstellung von Halogengasen
AU6128900A (en) 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6537552B1 (en) 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
IL159349A0 (en) * 2001-07-02 2004-06-01 Pfizer Prod Inc One dose vaccination with mycoplasma hyopneumoniae
US7655413B2 (en) * 2003-06-26 2010-02-02 Lifesensors, Inc. Methods and compositions for enhanced protein expression and purification
BR0306775A (pt) * 2003-12-23 2005-10-04 Conselho Nacional Cnpq Polinucleotìdeos codificadores de atividades do cromossomo da bactéria mycoplasma hyopneumoniae
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
TW200951219A (en) 2008-05-06 2009-12-16 Academia Sinica An improved SUMO fusion protein system for effective production of native proteins
AU2010215858A1 (en) * 2009-02-20 2011-09-22 Cdg Thereapeutics, Inc. Compositions and methods to prevent and/or treat cancer with Pa -CARD
CN101638435B (zh) * 2009-09-04 2011-11-16 暨南大学 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用

Also Published As

Publication number Publication date
US20170182142A1 (en) 2017-06-29
KR101775434B1 (ko) 2017-09-06
KR101831318B1 (ko) 2018-02-22
EP2955192B1 (en) 2020-07-01
MX355078B (es) 2018-04-03
KR20170082656A (ko) 2017-07-14
US20150366959A1 (en) 2015-12-24
ES2812552T3 (es) 2021-03-17
JP2016514086A (ja) 2016-05-19
US9750790B2 (en) 2017-09-05
PH12015501716A1 (en) 2015-11-09
US20170196959A1 (en) 2017-07-13
KR20170082657A (ko) 2017-07-14
MX370715B (es) 2019-12-20
KR101775435B1 (ko) 2017-09-06
RU2636459C2 (ru) 2017-11-23
EP2955192A4 (en) 2016-11-23
KR20150107767A (ko) 2015-09-23
EP3733691A1 (en) 2020-11-04
KR20170081759A (ko) 2017-07-12
EP2955192A1 (en) 2015-12-16
DK2955192T3 (en) 2020-08-17
TW201431873A (zh) 2014-08-16
CN104918953B (zh) 2019-04-02
US9775893B2 (en) 2017-10-03
KR101773486B1 (ko) 2017-08-31
US20170182144A1 (en) 2017-06-29
KR101758778B1 (ko) 2017-07-18
TWI609878B (zh) 2018-01-01
KR20170081760A (ko) 2017-07-12
US9561267B2 (en) 2017-02-07
US9750792B2 (en) 2017-09-05
KR20170081757A (ko) 2017-07-12
CN104918953A (zh) 2015-09-16
US9730990B2 (en) 2017-08-15
US20170202942A1 (en) 2017-07-20
KR101764750B1 (ko) 2017-08-03
WO2014121433A1 (zh) 2014-08-14
US9757441B2 (en) 2017-09-12
KR20170081758A (ko) 2017-07-12
UA116431C2 (uk) 2018-03-12
JP6113306B2 (ja) 2017-04-12
MX2015010102A (es) 2016-04-27
US9750791B2 (en) 2017-09-05
UA115348C2 (uk) 2017-10-25
PH12015501716B1 (en) 2015-11-09
US20170182143A1 (en) 2017-06-29
EP3733690A1 (en) 2020-11-04
RU2015137851A (ru) 2017-03-14
US20170151318A1 (en) 2017-06-01
KR101838160B1 (ko) 2018-03-13

Similar Documents

Publication Publication Date Title
BR112015018444A2 (pt) composição para prevenir infecção de mycoplasma spp., e vetor de expressão
BR112014030278A2 (pt) anticorpo, e, composição.
DK2986726T3 (da) Hidtil ukendte bacillusstammesammensætninger
BR302014001376S1 (pt) Configuração aplicada em bolsa.
BR112015017663A2 (pt) código de exceção de vetor
DK2975030T3 (da) Dihydropyridazin-3,5-dion-derivat
DK2873733T4 (da) Vektorer til transformation af mycoplasma hyopneumoniae, transformede m. hyopneumoniae-stammer og anvendelse deraf
DK3862031T3 (da) Smurte, oleofile katetre
DK3003493T3 (da) Enzymatisk system, som indeholder kosmetiske sammensætninger
BR112015022729A2 (pt) cortador de rolete com vedação aperfeiçoada.
FR3002452B1 (fr) Composition dermatologique antimicrobienne topique
DK3273797T3 (da) Sammensætning til at inhibere gram-positive, patogene bakterier
ITUB20152923A1 (it) Infisso ad elevata resistenza agli agenti atmosferici.
BR112016008035A2 (pt) composição, uso da composição
BR112016010562A2 (pt) composição antitranspirante.
BR302013006423S1 (pt) Configuração aplicada em fechadura.
BR302013006684S1 (pt) Configuração aplicada em garrafa.
BR302013002358S1 (pt) Configuração aplicada em frasco.
BR302013005266S1 (pt) Configuração aplicada em bloco.
TH1501001836A (th) การเคลือบและการอัดซ้อนที่ต้านทานการขูดขีดที่ใสยิ่ง
BR302013001503S1 (pt) Configuração aplicada em bola.
BR302013001903S1 (pt) Configuração aplicada em rede.
BR302013004433S1 (pt) Configuração aplicada em rack.
BR302013004427S1 (pt) Configuração aplicada em rack.
UA25343S (uk) Підшипник ковзання

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements